New 2025 Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee Group Practice Harmonisation and Guidelines Committee 1st listed author Guillermo Ortí Journal Bone Marrow Transplant.
New 2025 Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party Group Transplant Complications Working Party (TCWP) 1st listed author Nico Gagelmann Journal Blood Cancer J.
New 2025 Prognostic significance of cytogenetic risk score in patients with secondary acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-matched unrelated donors: a study from the ALWP /EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
New 2025 Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10) Group Infectious Diseases Working Party (IDWP) 1st listed author Simone Cesaro Journal Leukemia.
New 2025 Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMT Group Infectious Diseases Working Party (IDWP) 1st listed author Katia Perruccio Journal Bone Marrow Transplant.
2025 Progressive Multifocal Leukoencephalopathy (PML) after hematopoietic cell transplantation (HCT): a retrospective study of Infectious Diseases Working Party (IDWP) of the EBMT Group Infectious Diseases Working Party (IDWP) 1st listed author Jarosław Dybko Journal Bone Marrow Transplant.
2025 Improved outcomes over time in patients aged ≥60 years undergoing allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in first complete remission: a large study by the EBMT acute leukemia working party Group Acute Leukemia Working Party (ALWP) 1st listed author Nour Moukalled Journal Bone Marrow Transplant.
2025 Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia: a study of the SAAWP EBMT Group Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author Juan Montoro Journal Bone Marrow Transplant.
2025 Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition Group Lymphoma Working Party (LWP) GoCART Coalition 1st listed author Anna Ossami Saidy Journal Hemasphere.
2025 Addition of mycophenolate mofetil to a calcineurin inhibitor and post-transplant cyclophosphamide results in lower incidence of extensive chronic graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in complete remission: a matched-pair analysis on behalf of the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Giorgia Battipaglia Journal Bone Marrow Transplant.
2025 CAR-T cell manufacturing failures and out-of-specification products in the real-world setting: A survey from the EBMT cellular therapy and immunobiology working party Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Nina Worel Journal Bone Marrow Transplant.
2025 International expert consensus statement on PICU admission and early critical care management for paediatric patients following haematopoietic cell transplant and immune effector cell therapy Group Paediatric Diseases Working Party (PDWP) WP/Committee not specified 1st listed author Matteo Di Nardo Journal Lancet Child Adolesc Health.